PharmiWeb.com - Global Pharma News & Resources

OMass Therapeutics

Research & Development

OMass is an Oxford University spin-out backed by Syncona Ltd and Oxford Sciences Innovation that is harnessing high-resolution native mass spectrometry and other biophysical technologies to drive drug discovery in high definition for immunology and genetic disease.